NCT04233710 (RoboCP) is a Phase 2 clinical trial of Robot Rehabilitation + tDCS in Hemiplegic Cerebral Palsy, sponsored by University of Calgary.

Who is sponsoring NCT04233710?

NCT04233710 is sponsored by University of Calgary.

What drugs are being tested in NCT04233710?

Interventions in NCT04233710: Robot Rehabilitation + tDCS, Robotic Rehabilitation + sham tDCS.

What condition does NCT04233710 study?

NCT04233710 studies Hemiplegic Cerebral Palsy, Perinatal Stroke.

Is NCT04233710 still recruiting?

NCT04233710 is currently status unknown. Last updated 18 January 2020.

Last reviewed 2020-01-18 · How we verify

NCT04233710: RoboCP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Robotic Rehabilitation and Brain Stimulation for Children With Hemiparetic Cerebral Palsy

Status unknown Phase 2 Last updated 18 January 2020

What this trial tests

Phase 2 trial testing Robot Rehabilitation + tDCS in Hemiplegic Cerebral Palsy in 20 participants. Status unknown.

Timeline

25 March 2019

Primary endpoint
31 December 2020

31 December 2021

Quick facts

Lead sponsor	University of Calgary
Phase	Phase 2
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	20
Start date	25 March 2019
Primary completion	31 December 2020
Estimated completion	31 December 2021
Sites	1 location across Canada

Drugs / interventions tested

Robot Rehabilitation + tDCS
Robotic Rehabilitation + sham tDCS

Conditions studied

Hemiplegic Cerebral Palsy — all drugs for Hemiplegic Cerebral Palsy →
Perinatal Stroke — all drugs for Perinatal Stroke →

Sponsor

University of Calgary

Who can join

Adults 6 to 18, any sex, with Hemiplegic Cerebral Palsy or Perinatal Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the use of robotic rehabilitation with and without transcranial direct current stimulation (tDCS) to improve motor performance in children with hemiparetic cerebral palsy. Half of the participants will receive robotic rehabilitation and half will receive robotic rehabilitation with tDCS. We hypothesize that tDCS may augment the robotic therapy and show greater improvements than robotic therapy alone.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Robotic Rehabilitation and Transcranial Direct Current Stimulation in Children With Bilateral Cerebral Palsy.
Raess L, Hawe RL, Metzler M, Zewdie E, et al · · 2022 · cited 4× · PMID 36188922 · DOI 10.3389/fresc.2022.843767

Verify or expand the search:

Other recruiting trials for Hemiplegic Cerebral Palsy

Currently open trials in the same condition.

NCT07244081 — Kinesiotherapy on Upper Limb Function and Activities of Daily Living in Children With Hemiplegic Cerebral Palsy · NA · recruiting
NCT07233824 — Effects of Fun-Core (Child-Friendly Core Stabilization) Exercises on Balance and Functional Mobility in Children With Sp · NA · recruiting
NCT07401108 — Reactive Balance Training vs Virtual Reality in Hemiplegic Cerebral Palsy · NA · active not recruiting
NCT06846190 — Modified Constraint Induced Movement Therapy Versus Virtual Reality Training in Children With Cerebral Palsy · NA · recruiting
NCT06486987 — CHAMP T 2 Pilot of CIMT by Tele-Video · NA · active not recruiting

Other University of Calgary trials

Trials by the same sponsor.

NCT06885996 — Psilocybin-assisted Therapy for Post-Traumatic Stress Disorder in Survivors of Intimate Partner Violence · Phase 2 · not yet recruiting
NCT05729503 — Effect of SPG Block for Patients With Anxiety at Electronic Dance Music Festivals · Phase 2 · not yet recruiting
NCT07463339 — Microbiome-guided Prophylaxis to Reduce Ventilator-Associated Pneumonia in Intensive Care Units: A Pilot Randomized Cont · Phase 2 · not yet recruiting
NCT07145645 — Topical Diclofenac vs.Oral Ibuprofen for MSK Pain in Children · Phase 3 · recruiting
NCT07280325 — Moxie Self-Management and Education Support Program · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04233710 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Calgary
Last refreshed: 18 January 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04233710.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing